# EDGAR Filing Document

**Accession Number:** 0000927066
**File Stem:** 0000927066-23-000070
**Filing Date:** 2023-3
**Character Count:** 5238
**Document Hash:** 595e39890bb80aa0fc5ceaaa38dbc270
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000927066-23-000070.hdr.sgml**: 20230321

**ACCESSION NUMBER**: 0000927066-23-000070

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20230315

**ITEM INFORMATION**: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

**FILED AS OF DATE**: 20230321

**DATE AS OF CHANGE**: 20230321

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** DAVITA INC.
- **CENTRAL INDEX KEY:** 0000927066
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
- **IRS NUMBER:** 510354549
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-14106
- **FILM NUMBER:** 23747793

**BUSINESS ADDRESS:**
- **STREET 1:** 2000 16TH STREET
- **CITY:** DENVER
- **STATE:** CO
- **ZIP:** 80202
- **BUSINESS PHONE:** 310-536-2668

**MAIL ADDRESS:**
- **STREET 1:** 2000 16TH STREET
- **CITY:** DENVER
- **STATE:** CO
- **ZIP:** 80202

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** DAVITA HEALTHCARE PARTNERS INC.
- **DATE OF NAME CHANGE:** 20121107

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** DAVITA INC
- **DATE OF NAME CHANGE:** 20001005

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** TOTAL RENAL CARE HOLDINGS INC
- **DATE OF NAME CHANGE:** 19950524

?xml version="1.0" ? dva-20230315

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

**Form 8-K** 

**CURRENT REPORT** 

**Pursuant to Section 13 or 15(d) of the** 

**Securities Exchange Act of 1934** 

**Date of Report (date of earliest event reported): March 15, 2023** 

**DAVITA INC.** 

**(Exact name of registrant as specified in its charter)** 

---

| | | |
|:---|:---|:---|
| **DE** | **1-14106** | **51-0354549** |
| **(State or other jurisdiction<br>of incorporation)** | **(Commission File Number)** | **(IRS Employer<br>Identification No.)** |

---

---

| | | |
|:---|:---|:---|
| **2000 16th Street** | **2000 16th Street** | **2000 16th Street** |
| **Denver,** | **CO** | **80202** |

---

 **(Address of principal executive offices including Zip Code)** 

**(720) 631-2100** 

 **(Registrant's telephone number, including area code)** 

**Not applicable** 

**(Former name or former address, if changed since last report)** 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐&nbsp;&nbsp;&nbsp;&nbsp;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 240.425)

☐&nbsp;&nbsp;&nbsp;&nbsp;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐&nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐&nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class:** | **Trading symbol(s):** | **Name of each exchange on which registered:** |
| **Common Stock, $0.001 par value** | **DVA** | **New York Stock Exchange** |

---

------

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

☐&nbsp;&nbsp;&nbsp;&nbsp;Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.**

On March 15, 2023, John Winstel, Chief Accounting Officer of DaVita Inc. (the "Company") notified the Company of his decision to step down from his position, with an expected transition period to end no later than September 5, 2023 (the "Effective Date"). The decision was not as a result of any disagreement with the Company or its independent registered public accounting firm on any matter relating to the Company's financial or accounting operations, policies or practices or otherwise. Mr. Winstel is planning to continue in his role through the Effective Date, or until a successor is named by the Company, if earlier. The Company has commenced a search process for Mr. Winstel's successor.

------

**SIGNATURES** 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | DAVITA INC. | DAVITA INC. |
| Date: March 21, 2023 | By: | /s/ Kathleen A. Waters |
|  |  | Kathleen A. Waters |
|  |  | Chief Legal and Public Affairs Officer |

---